Most regulated commercial organisations measure activity. A few measure output. Almost none measure what the strategy actually requires: behavioural change. This article defines the complete three-tier measurement architecture, cross-channel attribution, dashboard design, and documented BCB benchmark ranges across three sectors.
Three systematic pathologies produce the same commercial outcome: an organisation that does not know whether its marketing investment is working.
The BCB Framework™ resolves all three through a single architectural decision: measurement is designed from the Behavioral Objective backwards. The behavioral outcome is defined first; the campaign KPIs that predict movement toward it are defined second; the content KPIs measuring the operational health of the system producing the campaign are defined third. The resulting hierarchy is coherent, causal, and commercially interpretable.
Three tiers, hierarchical: Tier 1 Behavioral KPIs are commercially primary; Tier 2 Campaign KPIs are leading indicators; Tier 3 Content KPIs measure the system producing the campaign. A Tier 3 failure eventually manifests at Tier 2, then Tier 1.
The hierarchy resolves the proliferation problem directly: any metric that cannot be placed within it — that does not contribute to a Tier 2 or Tier 1 KPI — is not a commercial metric. It may be operational, hygiene, or vanity. The discipline: if a metric cannot be connected to a specific behavioral outcome, it should not appear on the primary commercial dashboard.
Tier 3 — foundational, not primary. A content system failing at this level constrains commercial performance at Tier 2 and Tier 1.
Tier 2 — leading indicators of behavioral achievement. Every campaign KPI must be contextualised by its relationship to the Tier 1 outcome it is intended to predict.
The distinction between a vanity metric and a value metric is not the metric itself — it is whether it has been connected to a behavioral outcome.
| Vanity Metric | Why It Misleads | Value Equivalent |
|---|---|---|
| Email open rate | Measures receipt, not engagement or intent | Click-to-content rate × funnel stage progression within 14 days |
| Rep call completion rate | Measures access, not quality | Rep call behavioural advance rate: % moving to next funnel stage within 30 days |
| Total portal sessions | Counts visits without distinguishing intent | Engagement depth score: pages viewed × time on clinical content × downloads |
| Event attendance | Measures presence, not impact | Post-event prescribing conversion rate within 60 days |
| Social media impressions | Not commercially differentiating in isolation | Professional network engagement leading to portal entry or event registration |
| Content asset downloads | Measures availability, not impact | Asset engagement depth: opens + scroll depth + time + correlation with prescribing |
Tier 1 — the primary commercial measures. Not proxies, not correlates: the commercial outcomes the strategy was designed to produce.
The discipline of defining Behavioral KPIs before building campaign or content architecture is the most consistently transformative change BCB introduces. Organisations that define them first design campaigns structured to produce them; organisations that define them after launch are measuring what happened, not managing toward what was required.
The most analytically challenging, and most frequently avoided or oversimplified, problem in regulated commercial measurement.
When an HCP writes a first prescription, which combination of touchpoints produced that outcome, and in what proportion? Most organisations avoid the question not because data is unavailable, but because any attribution model requires commercially contestable assumptions. The BCB approach: use attribution instrumentally, to answer specific commercial questions that improve future investment allocation — not to retrospectively assign credit.
| Attribution Model | What It Answers | Best Use in BCB |
|---|---|---|
| First Touch | Which channel first engaged an HCP who subsequently prescribed? | Measuring awareness channel effectiveness at Stage 01→02 |
| Last Touch | Which touchpoint was final before the prescribing event? | Identifying closing triggers at the Evaluating stage |
| Linear Multi-Touch | Which channels appear in the typical prescribing journey? | Mapping the full commercial journey architecture |
| Time-Decay | Which recent touchpoints are most associated with conversion? | Optimising the closing phase, Stages 04–05 |
| Data-Driven (ML) | Which touchpoint sequence produces the highest conversion probability? | NBA model input — requires 12–18 months of labeled data |
Three tiers corresponding to the KPI hierarchy, each with a distinct audience, cadence, and decision purpose. A single dashboard for all three is the most common measurement architecture error.
The governance architecture should define, for each tier: who owns the data, who reviews it and how often, what decision authority rests with each tier’s owners, and what escalation pathway exists when a KPI falls below threshold. A Tier 3 metric falling below threshold — MLR cycle time beyond 6 weeks — should trigger escalation to Tier 2 before it manifests as a campaign delivery failure.
Drawn from documented BCB Framework™ engagements across three sectors — the range of outcomes observed in real deployments, not modeled projections.